Analysis of Phase I Clinical Trial Design of Anti-Cancer Agents
Crossref DOI link: https://doi.org/10.1007/s43441-025-00830-x
Published Online: 2025-06-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cho, Juhee
Bok, Haesook
Jo, Taeyoun
Ahn, Sohyun
Text and Data Mining valid from 2025-06-21
Version of Record valid from 2025-06-21
Article History
Received: 13 September 2024
Accepted: 17 June 2025
First Online: 21 June 2025
Declarations
:
: The authors declare no competing interests.